| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Medpace Holdings, Inc. (MEDP) have been net sellers, shedding 23,587 shares worth roughly $11.7M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. MEDP sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 638.9K | $381.44M | -7,238 | |
| VP | 47.5K | $28.36M | - | |
| Other | 20.3K | $12.14M | - | |
| Pres | 15.0K | $8.95M | - | |
| CFO | 5.8K | $3.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26, 2021 | Medpace Investors, LLC69 | 10% Owner | Sell | 28,534 | $192.59 | $5,495,504.57 | -0.2% | -6.6% | -31.8% | |
| Apr 22, 2021 | Troendle August J.70 | President &CEO | Sell | 30,064 | $187.79 | $5,645,860.02 | -0.2% | -2.7% | -19.7% | |
| Apr 22, 2021 | Medpace Investors, LLC69 | 10% Owner | Sell | 30,064 | $187.79 | $5,645,860.02 | -0.2% | -2.7% | -19.7% | |
| Apr 20, 2021 | Troendle August J.70 | President &CEO | Sell | 26,094 | $181.94 | $4,747,544.02 | -0.2% | -4.3% | -13.1% | |
| Apr 20, 2021 | Medpace Investors, LLC69 | 10% Owner | Sell | 26,094 | $181.94 | $4,747,544.02 | -0.2% | -4.3% | -13.1% | |
| Apr 16, 2021 | Medpace Investors, LLC69 | 10% Owner | Sell | 52,518 | $184.09 | $9,668,229.50 | -0.3% | +1.3% | -15.3% | |
| Apr 16, 2021 | Troendle August J.70 | President &CEO | Sell | 52,518 | $184.09 | $9,668,229.50 | -0.3% | +1.3% | -15.3% | |
| Apr 15, 2021 | Ewald Stephen P58 | General Counsel &Corp. Secy. | Sale+OE | 5,000 | $184.10 | $920,488.00 | -15.3% | -1.1% | -14.5% | |
| Apr 14, 2021 | Geiger Jesse J57 | CFO &COO, Lab Operations | Sale+OE | 3,000 | $180.00 | $540,000.00 | -32.0% | +3.2% | -11.1% | |
| Mar 3, 2021 | Burwig Susan E62 | Exec. VP, Operations | Sell | 6,211 | $167.00 | $1,037,237.00 | -8.1% | - | - |